In one paragraphArticle in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
13 authors.
Louise Antonia HendrickxCampus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium.
Xiaoyi ShiAG Oncophysiology, Max-Planck Institute for Multidisciplinary Sciences, Hermann-Rein-Str. 3, 37075 Göttingen, Germany.
Kenny M Van TheemscheLaboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.
Ernesto Lopes Pinheiro-JuniorCampus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium.ORCID 0000-0001-6050-8285 Steve PeigneurCampus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium.ORCID 0000-0003-0504-5702 Alain J LabroLaboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0002-0871-7511 Luis A PardoAG Oncophysiology, Max-Planck Institute for Multidisciplinary Sciences, Hermann-Rein-Str. 3, 37075 Göttingen, Germany.ORCID 0000-0003-1375-4349 Jan TytgatCampus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium.
Lucija Peterlin MašičFaculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.ORCID 0000-0003-0624-8472 Funding
KU Leuven PDM/19/164Max Planck Society No. 813834-PHIONIC-H2020-MSCA-ITN-2018.Research Foundation - Flanders GOE7120N, GOC2319N, and GOA4919NResearch Foundation - Flanders Vlaanderen grant 12W7822NSlovenian Research Agency J1-9192, N1-0098, P1-0245
6 · The paper itselfAbstract
In the original publication [...].
Identifiers
PMID37297027
PMCPMC10252048
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390